A program celebrating Twyla Tharp’s 60th year making dances features the masterwork “Diabelli” and the fresh new “Slacktide,” ...

Please view our affiliate disclosure. Artificial intelligence has significantly advanced the field of character creation, providing artists, writers, and developers with powerful tools to realize ...

In 2023, the US Food and Drug Administration approved Rystiggo and Zilbrysq for the treatment of adults with generalized myasthenia gravis. UCB acquired Zilbrysq through its acquisition of Ra ...

We assume peak Vyvgart sales of more than $4 billion in myasthenia gravis, with two competing drugs launched by UCB in 2023 (FcRn antibody Rystiggo and complement drug Zilbrysq), and positive ...

5.61 billion (+17% CER 1) driven by a strong, triple- and double-digit growth performance of newly launched growth drivers: BIMZELX ®, EVENITY ®, FINTEPLA ®, RYSTIGGO ® and ZILBRYSQ ® as well ...

Revenue in 2024 increased to € 6.15 billion, a plus of 17% (+19% CER 1), ...

BIMZELX ®, EVENITY ®, FINTEPLA ®, RYSTIGGO ® and ZILBRYSQ ® as well as solid contribution from CIMZIA ® and BRIVIACT ® reaching its peak sales two years ahead of target Underlying ...

C5 inhibitor Zilbrysq (zilucoplan), and FcRn-targeting antibody Rystiggo (rozanolixizumab). Approval in CIDP would allow Netherlands-based Argenx to carve out a niche for its product.

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...

Many video games feature a character creation system, but which ones are the best? Well, don’t wonder any longer! We narrowed down the best character creation games based on games with good ...